{"id":62263,"date":"2025-11-26T22:05:13","date_gmt":"2025-11-26T21:05:13","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/feinstein-institutes-secures-3-37m-grant-to-strengthen-first-responder-mental-health-and-resilience\/"},"modified":"2025-11-26T22:05:13","modified_gmt":"2025-11-26T21:05:13","slug":"feinstein-institutes-secures-3-37m-grant-to-strengthen-first-responder-mental-health-and-resilience","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/feinstein-institutes-secures-3-37m-grant-to-strengthen-first-responder-mental-health-and-resilience\/","title":{"rendered":"Feinstein Institutes secures $3.37M grant to strengthen first responder mental health and resilience"},"content":{"rendered":"
\n

\nNew research study aims to treat PTSD and depression, in collaboration with Stony Brook University and Texas A&M<\/i>\n<\/p>\n

MANHASSET, N.Y.–(BUSINESS WIRE)–Recent reports show that one in seven first responders<\/a> have probable post-traumatic stress disorder (PTSD) in response to routine duties with prevalence increasing after responding to a crisis. To improve our understanding and the well-being of these essential heroes, researchers at Northwell Health\u2019s<\/a> Feinstein Institutes for Medical Research<\/a>, Stony Brook University and Texas A&M University received a $3.37-million grant from the National Institute of Mental Health (NIMH). The five-year, multi-site clinical trial aims to significantly improve the mental health and resilience of first responders across the nation.\n<\/p>\n

<\/a>
<\/a>
<\/a>
<\/a><\/p>\n

\nThe study, titled \u201cA Large-Scale Efficacy Trial of a Resilience Training Program for First Responders\u201d \u2013 led by Rebecca Schwartz, PhD<\/a>, associate professor at the Feinstein Institutes\u2019 Institute of Behavioral Science<\/a> and senior director of clinical research with Northwell\u2019s Department of Occupational Medicine, Epidemiology and Prevention<\/a>, along with Adam Gonzalez, PhD, of Stony Brook University and Anka Vujanovic, PhD, of Texas A&M \u2013 will conduct a large-scale efficacy trial of the Worker Resilience Training (WRT) program, an interactive workshop designed to equip first responders with crucial skills to manage stress, promote healthy lifestyle behaviors and prevent the development or worsening of mental health conditions like PTSD and depression.\n<\/p>\n

\n\u201cFirst responders face a heightened risk for mental health conditions due to chronic exposure to trauma; COVID-19 demonstrated that firsthand. It\u2019s our duty to support their well-being, especially their mental health,\u201d said Dr. Schwartz. \u201cThis NIMH grant allows us to rigorously test a preventative intervention that has the potential to significantly enhance resilience and reduce the burden of PTSD and depression in this critical population.\u201d\n<\/p>\n

\nEarlier research led by Drs. Gonzalez and Schwartz,<\/a> including a randomized clinical trial with Hurricane Sandy responders, demonstrated the WRT program\u2019s potential to prevent mental health symptoms and promote adaptive coping. Building on these promising initial results, the new study will rigorously evaluate the WRT program in 800 first responders in New York and Texas. The research will compare the clinical trial group to a time-matched control workshop.\n<\/p>\n

\nKey aims include measuring improvements in resilience indicators such as healthy lifestyle behaviors, stress management, physical activity and perceived resilience. A critical aspect of the study is to determine if the WRT program effectively prevents the development or worsening of psychological symptoms and functional impairments in first responders who are exposed to traumatic events after participating in the workshop.\n<\/p>\n

\n\u201cThe COVID-19 pandemic highlighted the toll of chronic stress on first responders,\u201d said Kevin J. Tracey, MD,<\/a> president and CEO of the Feinstein Institutes and Karches Family Distinguished Chair in Medical Research. \u201cDr. Schwartz\u2019s research provides scientific insights and new strategies to enhance mental well-being and resilience for essential workers.\u201d\n<\/p>\n

\nThis research holds significant public health implications by providing an evidence-based, scalable, and impactful preventative intervention. It has the potential to reduce personal and financial costs for responders, their families and society at large.\n<\/p>\n

\nAbout the Feinstein Institutes<\/i><\/b>\n<\/p>\n

\nThe Feinstein Institutes for Medical Research<\/i><\/a> is the home of the research institutes of Northwell Health, the largest health care provider and private employer in New York State. Encompassing 50+ research labs, 3,000 clinical research studies and 5,000 researchers and staff, the Feinstein Institutes raises the standard of medical innovation through its six institutes of behavioral science, bioelectronic medicine, cancer, health system science, molecular medicine, and translational research. We are the global scientific leader in bioelectronic medicine \u2013 an innovative field of science that has the potential to revolutionize medicine. The Feinstein Institutes publishes two open-access, international peer-reviewed journals <\/i>Molecular Medicine<\/i><\/a> and <\/i>Bioelectronic Medicine<\/i><\/a>. Through the <\/i>Elmezzi Graduate School of Molecular Medicine<\/i><\/a>, we offer an accelerated PhD program. For more information about how we produce knowledge to cure disease, visit <\/i>http:\/\/feinstein.northwell.edu<\/i><\/a> and follow us on <\/i>LinkedIn<\/i><\/a>.<\/i>\n<\/p>\n

Contacts<\/b> <\/p>\n

\nJulianne Mosher Allen
\n
516-880-4824
\n
jmosherallen@northwell.edu<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

New research study aims to treat PTSD and depression, in collaboration with Stony Brook University and Texas A&M MANHASSET, N.Y.–(BUSINESS WIRE)–Recent reports show that one in seven first responders have probable post-traumatic stress disorder (PTSD) in response to routine duties with prevalence increasing after responding to a crisis. To improve our understanding and the well-being … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-62263","6":"format-standard","7":"category-industry"},"yoast_head":"\nFeinstein Institutes secures $3.37M grant to strengthen first responder mental health and resilience - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/feinstein-institutes-secures-3-37m-grant-to-strengthen-first-responder-mental-health-and-resilience\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Feinstein Institutes secures $3.37M grant to strengthen first responder mental health and resilience - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"New research study aims to treat PTSD and depression, in collaboration with Stony Brook University and Texas A&M MANHASSET, N.Y.–(BUSINESS WIRE)–Recent reports show that one in seven first responders have probable post-traumatic stress disorder (PTSD) in response to routine duties with prevalence increasing after responding to a crisis. To improve our understanding and the well-being ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/feinstein-institutes-secures-3-37m-grant-to-strengthen-first-responder-mental-health-and-resilience\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-26T21:05:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20251126640655\/en\/2655001\/22\/RS3.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/feinstein-institutes-secures-3-37m-grant-to-strengthen-first-responder-mental-health-and-resilience\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/feinstein-institutes-secures-3-37m-grant-to-strengthen-first-responder-mental-health-and-resilience\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Feinstein Institutes secures $3.37M grant to strengthen first responder mental health and resilience\",\"datePublished\":\"2025-11-26T21:05:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/feinstein-institutes-secures-3-37m-grant-to-strengthen-first-responder-mental-health-and-resilience\\\/\"},\"wordCount\":664,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/feinstein-institutes-secures-3-37m-grant-to-strengthen-first-responder-mental-health-and-resilience\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251126640655\\\/en\\\/2655001\\\/22\\\/RS3.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/feinstein-institutes-secures-3-37m-grant-to-strengthen-first-responder-mental-health-and-resilience\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/feinstein-institutes-secures-3-37m-grant-to-strengthen-first-responder-mental-health-and-resilience\\\/\",\"name\":\"Feinstein Institutes secures $3.37M grant to strengthen first responder mental health and resilience - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/feinstein-institutes-secures-3-37m-grant-to-strengthen-first-responder-mental-health-and-resilience\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/feinstein-institutes-secures-3-37m-grant-to-strengthen-first-responder-mental-health-and-resilience\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251126640655\\\/en\\\/2655001\\\/22\\\/RS3.jpg\",\"datePublished\":\"2025-11-26T21:05:13+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/feinstein-institutes-secures-3-37m-grant-to-strengthen-first-responder-mental-health-and-resilience\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/feinstein-institutes-secures-3-37m-grant-to-strengthen-first-responder-mental-health-and-resilience\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/feinstein-institutes-secures-3-37m-grant-to-strengthen-first-responder-mental-health-and-resilience\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251126640655\\\/en\\\/2655001\\\/22\\\/RS3.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251126640655\\\/en\\\/2655001\\\/22\\\/RS3.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/feinstein-institutes-secures-3-37m-grant-to-strengthen-first-responder-mental-health-and-resilience\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Feinstein Institutes secures $3.37M grant to strengthen first responder mental health and resilience\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Feinstein Institutes secures $3.37M grant to strengthen first responder mental health and resilience - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/feinstein-institutes-secures-3-37m-grant-to-strengthen-first-responder-mental-health-and-resilience\/","og_locale":"en_US","og_type":"article","og_title":"Feinstein Institutes secures $3.37M grant to strengthen first responder mental health and resilience - Pharma Trend","og_description":"New research study aims to treat PTSD and depression, in collaboration with Stony Brook University and Texas A&M MANHASSET, N.Y.–(BUSINESS WIRE)–Recent reports show that one in seven first responders have probable post-traumatic stress disorder (PTSD) in response to routine duties with prevalence increasing after responding to a crisis. To improve our understanding and the well-being ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/feinstein-institutes-secures-3-37m-grant-to-strengthen-first-responder-mental-health-and-resilience\/","og_site_name":"Pharma Trend","article_published_time":"2025-11-26T21:05:13+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20251126640655\/en\/2655001\/22\/RS3.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/feinstein-institutes-secures-3-37m-grant-to-strengthen-first-responder-mental-health-and-resilience\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/feinstein-institutes-secures-3-37m-grant-to-strengthen-first-responder-mental-health-and-resilience\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Feinstein Institutes secures $3.37M grant to strengthen first responder mental health and resilience","datePublished":"2025-11-26T21:05:13+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/feinstein-institutes-secures-3-37m-grant-to-strengthen-first-responder-mental-health-and-resilience\/"},"wordCount":664,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/feinstein-institutes-secures-3-37m-grant-to-strengthen-first-responder-mental-health-and-resilience\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20251126640655\/en\/2655001\/22\/RS3.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/feinstein-institutes-secures-3-37m-grant-to-strengthen-first-responder-mental-health-and-resilience\/","url":"https:\/\/pharma-trend.com\/en\/feinstein-institutes-secures-3-37m-grant-to-strengthen-first-responder-mental-health-and-resilience\/","name":"Feinstein Institutes secures $3.37M grant to strengthen first responder mental health and resilience - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/feinstein-institutes-secures-3-37m-grant-to-strengthen-first-responder-mental-health-and-resilience\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/feinstein-institutes-secures-3-37m-grant-to-strengthen-first-responder-mental-health-and-resilience\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20251126640655\/en\/2655001\/22\/RS3.jpg","datePublished":"2025-11-26T21:05:13+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/feinstein-institutes-secures-3-37m-grant-to-strengthen-first-responder-mental-health-and-resilience\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/feinstein-institutes-secures-3-37m-grant-to-strengthen-first-responder-mental-health-and-resilience\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/feinstein-institutes-secures-3-37m-grant-to-strengthen-first-responder-mental-health-and-resilience\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20251126640655\/en\/2655001\/22\/RS3.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20251126640655\/en\/2655001\/22\/RS3.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/feinstein-institutes-secures-3-37m-grant-to-strengthen-first-responder-mental-health-and-resilience\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Feinstein Institutes secures $3.37M grant to strengthen first responder mental health and resilience"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62263","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=62263"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62263\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=62263"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=62263"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=62263"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}